Together, these results strongly suggest that Adam11’s ability to restrict β-catenin activity and delay EMT in the CNC is conserved in adult tissues and that loss of ADAM11 may contribute to β-catenin hyperactivation and CYCLIND1 overexpression, leading to tumor progression and metastasis. This evidence concerns the gene ADAM11 and neoplasm.